Mirion Medical Group President Michael Rossi resigns Nov 1; CEO Logan steps in

Mirion Technologies, Inc.

Michael Rossi resigns as Medical Group President, effective Nov 1, 2023, to become CEO at another public company.
CEO Thomas Logan reassumes Medical Group President duties until a permanent successor is named.
Rossi’s resignation is not due to any disagreement with the Company regarding operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Rossi

Medical Group President

MIR · Mirion Technologies, Inc.

Effective: 2023-11-01
Filed: October 18, 2023, 7:59 PM ET

On October 13, 2023, Mr. Michael Rossi, who has served as the Medical Group President of Mirion Technologies, Inc. (the “Company”), notified the Company of his decision to resign from his position, effective November 1, 2023, in order to assume a CEO role at another public company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Rossi resigned as Medical Group President at Mirion Technologies, Inc..

Action: resigned
Role: Medical Group President

Exact text from the filing

On October 13, 2023, Mr. Michael Rossi, who has served as the Medical Group President of Mirion Technologies, Inc. (the “Company”), notified the Company of his decision to resign from his position, effective November 1, 2023, in order to assume a CEO role at another public company.

View on SEC.gov

Mirion Technologies, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-034594

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.